Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 132

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 132
---
 return or reimburse the Company all
or a portion of the award or shares issued under the award, any amounts paid under the award and any payments or proceeds paid or provided
upon disposition of the shares issued under the award in order to comply with such clawback policy or applicable laws.

Amendment
and Termination

The
administrator has the authority to amend, suspend or terminate the 2023 Plan provided such action does not impair the existing rights
of any participant. The 2023 Plan automatically will terminate on October 4, 2033, unless it is terminated sooner.

113

Director
Compensation 

Prior
to our 2024 initial public offering, we did not have a formal policy to compensate our non-employee directors. Following our initial
public offering, our non-employee directors are eligible to receive the following cash retainers and equity awards. The retainers will
be payable in four equal installments in each calendar quarter and will be payable within five business days of the end of each calendar
quarter, and with such amount for any partial calendar quarter being appropriately prorated.

    Annual Retainer for Board Membership 

    Annual service on the board of directors 
    $30,000 
  
    Additional Annual Retainer for Committee Membership 

    Annual service as member of the audit committee (other than chair) 
    $5,000 
  
    Annual service as chair of the audit committee 
    $10,000 
  
    Annual service as member of the compensation committee (other than chair) 
    $5,000 
  
    Annual service as chair of the compensation committee 
    $10,000 
  
    Annual service as member of the nominating and corporate governance committee (other than chair) 
    $4,000 
  
    Annual service as chair of the nominating and corporate governance committee 
    $7,500 

Upon
initial election to our board of directors, each non-employee director will be granted an option to acquire up to 18,000 shares of the
common stock at an exercise price of $5.00 per share (subject to customary adjustments), which options shall vest ratably over 36 months,
subject to the director continuing to serve as a director of the Company during such period, pursuant to the Option Award Agreement.
During the term of the independent director agreements, the Company will reimburse each director for all reasonable out-of-pocket expenses
incurred by the director in attending any in-person meetings, provided that the director compl